Pharmacological mechanisms and therapeutic prospects of plant metabolites from traditional Chinese medicine in regulating programmed cell death in Alzheimer’s disease
Frontiers in Pharmacology · 24.09.2025 · 16
DOI: 10.3389/fphar.2025.1605214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.09.2025. Verfasst von Pengyu Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline and neuronal loss. Multiple forms of programmed cell death (PCD)—including apoptosis, pyroptosis, ferroptosis, cuproptosis, and disulfidoptosis—contribute to its pathogenesis, regulated by protein families such as caspases, RIPKs, gasdermins, and ATGs. Plant metabolites widely distributed across medicinal plants and enriched in botanical drugs used in traditional Chinese medicine (TCM), such as alkaloids, flavonoids, saponins, and polysaccharides, have attracted increasing attention for their potential regulatory effects on these PCD pathways. These metabolites are not unique to TCM, but their prevalence in TCM prescriptions provides a valuable framework for pharmacological investigation. Their biological activities are often determined by structural features—for example, the isoquinoline scaffold of berberine enhances membrane permeability, facilitating neuroprotective actions. Despite substantial research, comprehensive summaries remain limited. This review systematically integrates progress from the past 2 decades on how plant metabolites, particularly those enriched in TCM botanical drugs, regulate PCD in AD, with the aim of clarifying pharmacological mechanisms and highlighting prospects for drug discovery and clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
- Key Laboratory of Basic Theory Research on Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Pan, P., Zhao, T., Zhang, J., Zhou, Y., Zhang, X., Li, Q., & Zhou, Y. (2025). Pharmacological mechanisms and therapeutic prospects of plant metabolites from traditional Chinese medicine in regulating programmed cell death in Alzheimer’s disease. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1605214
Vancouver
Pan P, Zhao T, Zhang J, Zhou Y, Zhang X, Li Q, et al. Pharmacological mechanisms and therapeutic prospects of plant metabolites from traditional Chinese medicine in regulating programmed cell death in Alzheimer’s disease. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1605214
BibTeX
@article{Pan2025,
author = {Pan, Pengyu and Zhao, Tengyu and Zhang, Jian and Zhou, Yuhan and Zhang, Xinyue and Li, Quan and Zhou, Yanyan},
title = {Pharmacological mechanisms and therapeutic prospects of plant metabolites from traditional Chinese medicine in regulating programmed cell death in Alzheimer’s disease},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1605214}
}
EUVIMED